Compare IOST (IOST) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IOST vs Enzyme — how do they compare? IOST trades at Rp9.65 (market cap Rp336,11M, Rp60,67M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: IOST is far larger — about 2.5× Enzyme's market cap, and IOST's supply is capped (34,8B / 90B IOST (39%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold IOST for 79 Days and Enzyme for 29 Days on average.
| IOST | MLN | |
|---|---|---|
Market Cap | Rp336,11M | Rp134,13M |
Volume (24h) | Rp60,67M | Rp104,56M |
Circulating Supply | 34,8B / 90B IOST (39%) | 3,3M MLN |
Typical Hold Time | 79 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IOST is currently trading at Rp9.81 with a market cap of Rp339.2M, showing bearish technical signals overall despite some bullish oscillator readings. The token trades near key support levels with limited price movement range. With only 39% of max supply in circulation and average hold time of 79 days, the asset shows moderate network participation.
The outlook remains cautious due to strong bearish momentum indicators and limited fundamental developments. Key risks include low liquidity and concentrated trading near support levels, while potential upside exists if oversold RSI conditions trigger a reversal. Investors should monitor for protocol updates and exchange volume changes.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About IOST
IOST describes itself as an “ultra-fast,” fully fledged and decentralized blockchain network and ecosystem with its own nodes, wallets and based on the “next-generation” consensus protocol dubbed “proof-of-believability.”
Read more on IOST →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
